US 6245752
Compositions and methods for tolerization in immune complex-mediated disease progression
expired A61KA61K2039/6093A61K38/00
Quick answer
US patent 6245752 (Compositions and methods for tolerization in immune complex-mediated disease progression) held by BioCrystal, Ltd. expires Mon Jun 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- BioCrystal, Ltd.
- Grant date
- Tue Jun 12 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61K, A61K2039/6093, A61K38/00, A61K39/001169, A61K39/385